The China Debate: Biotech deserves a deeper discussion — see you in Boston

Endpoints launches The China Biotech Debate, a panel series in Cambridge, MA, on Aug. 6, with execs from Roivant, Pfizer, Ginkgo and RA Capital.

Raccontata daendpoints.news